[go: up one dir, main page]

WO2021221594A3 - Multi-probiotic oil combination containing borage oil and production method thereof - Google Patents

Multi-probiotic oil combination containing borage oil and production method thereof Download PDF

Info

Publication number
WO2021221594A3
WO2021221594A3 PCT/TR2021/050404 TR2021050404W WO2021221594A3 WO 2021221594 A3 WO2021221594 A3 WO 2021221594A3 TR 2021050404 W TR2021050404 W TR 2021050404W WO 2021221594 A3 WO2021221594 A3 WO 2021221594A3
Authority
WO
WIPO (PCT)
Prior art keywords
oil
lactobacillus
bifidobacterium
probiotic
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2021/050404
Other languages
French (fr)
Other versions
WO2021221594A2 (en
Inventor
Leyla Tarhan ÇELEBİ
Bekir ÇAKICI
İsmail ASLAN
Hülya KAYAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hly Aromaterapi Hizmetleri Kozmetik Sanayi Ticaret AS
Sfa Arge Ve Oezel Saglik Hizmetleri Ticaret Ltd Sirketi
Original Assignee
Hly Aromaterapi Hizmetleri Kozmetik Sanayi Ticaret AS
Sfa Arge Ve Oezel Saglik Hizmetleri Ticaret Ltd Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hly Aromaterapi Hizmetleri Kozmetik Sanayi Ticaret AS, Sfa Arge Ve Oezel Saglik Hizmetleri Ticaret Ltd Sirketi filed Critical Hly Aromaterapi Hizmetleri Kozmetik Sanayi Ticaret AS
Publication of WO2021221594A2 publication Critical patent/WO2021221594A2/en
Anticipated expiration legal-status Critical
Publication of WO2021221594A3 publication Critical patent/WO2021221594A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention particularly relates to a multi-probiotic and oil combination consisting of borage oil selected as fixed oil, which forms oily carriers, patchouli oil selected as essential oil, peppermint oil, myrrh oils with probiotic bacteria Akkermensia muciniphila, Lactobacillus gasseri, Bacillus clausii, Bacillus subtilis, Leuconostoc mesenteroides, Lactobacillus rhamnosus, Lactobacillus cameliae, Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Bacillus clausii, Lactococcus lactis, Streptococcus thermophilus developed to be used in health sector to be used in treatment and/or preventive treatments for osteoporosis regression, regression of menopause/andropause symptoms, prostaglandin/eicosanoid regulation, geriatric support and a production method thereof.
PCT/TR2021/050404 2020-04-30 2021-04-28 Multi-probiotic oil combination containing borage oil and production method thereof Ceased WO2021221594A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2020/06826 2020-04-30
TR202006826 2020-04-30

Publications (2)

Publication Number Publication Date
WO2021221594A2 WO2021221594A2 (en) 2021-11-04
WO2021221594A3 true WO2021221594A3 (en) 2022-11-10

Family

ID=78374187

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2021/050404 Ceased WO2021221594A2 (en) 2020-04-30 2021-04-28 Multi-probiotic oil combination containing borage oil and production method thereof

Country Status (1)

Country Link
WO (1) WO2021221594A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120058225A1 (en) * 2009-04-23 2012-03-08 Bacterfield Oü Probiotic oil suspension and use thereof
WO2018065324A1 (en) * 2016-10-03 2018-04-12 Ab-Biotics, S.A. Antiseptic-tolerant lactic acid bacteria
WO2018174938A1 (en) * 2017-03-23 2018-09-27 Virun, Inc. Stable dry powders and emulsions containing probiotics and mucoadhesive protein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120058225A1 (en) * 2009-04-23 2012-03-08 Bacterfield Oü Probiotic oil suspension and use thereof
WO2018065324A1 (en) * 2016-10-03 2018-04-12 Ab-Biotics, S.A. Antiseptic-tolerant lactic acid bacteria
WO2018174938A1 (en) * 2017-03-23 2018-09-27 Virun, Inc. Stable dry powders and emulsions containing probiotics and mucoadhesive protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Borage ", DRUGS.COM, 28 March 2013 (2013-03-28), XP093004825, Retrieved from the Internet <URL:https://web.archive.org/web/20130328125127/https://www.drugs.com/npp/borage.html> [retrieved on 20221205] *
COLLINS ET AL.: "The Potential of Probiotics as a Therapy for Osteoporosis", MICROBIOLOGY SPECTRUM, vol. 5, no. 4, 2017, XP055625516, Retrieved from the Internet <URL:https://www.researchgate.net/publication/319293495_The_Potential_of_Probiotics_as_a_Therapy_for_Osteoporosis> DOI: 10.1128/microbiolspec.BAD-0015-2016 *

Also Published As

Publication number Publication date
WO2021221594A2 (en) 2021-11-04

Similar Documents

Publication Publication Date Title
RU2010132283A (en) COMPOSITIONS, METHODS AND KITS FOR INCREASING THE IMMUNE RESPONSE TO RESPIRATORY DISEASE
Samot et al. Antibacterial activity of probiotic candidates for oral health
PE20020232A1 (en) LACTIC ACID BACTERIA SUCH AS LACTOBACILLUS, BIFIDOBACTERIUM AND STREPTOCOCCUS ISOLATED FOR THEIR PROBIOTIC POTENTIAL FOR PET FOOD APPLICATIONS
RU2011150201A (en) SHORT-TEMPERATURE TREATMENT FOR MICROBIAL DRUGS WITH ANTI-INFLAMMATORY PROPERTIES
RU2011150195A (en) MIX FOR NUTRITION FOR INFANTS AND YOUNG CHILDREN CONTAINING PROBIOTICS FOR INFANTS AND YOUNG CHILDREN
RU2013126616A (en) FROZEN CONFECTIONERY CONTAINING PROBIOTIC MICRO-ORGANISMS
RU2012140052A (en) COMPOSITION CONTAINING PROBIOTIC BACTERIA FOR USE IN THE TREATMENT OF IMMUNE DISORDERS
RU2014107770A (en) COMPOSITION COMPRISING N-ACETYLCYSTEINE AND / OR microencapsulated protected from gastric acid lysozyme IN COMBINATION WITH probiotic bacteria capable of reducing OWN BARRIER EFFECT stomach which expire during the treatment of gastric hyperacidity FARMALOGICHESKOGO
MY207753A (en) Composition for maintenance and/or improvement of memory/learning ability, and food, medicine and feed each containing said composition
JP2024026410A5 (en)
RU2018124827A (en) APPLICATION OF LACTASE IN PREPARATION OF DILUTED FERMENTED DAIRY PRODUCT
WO2019206754A8 (en) Composition and process for producing a fermented milk product comprising application of a lactose-deficient s. thermophilus strain, a lactose-deficient l. bulgaricus strain and a probiotic strain
NZ750450A (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
RU2018124857A (en) APPLICATION OF LACTASE TO IMPROVE THE QUALITY OF PREPARATION OF DILUTED FERMENTED DAIRY PRODUCT
RU2013126602A (en) NON-REPLICATING PROBIOTIC MICRO-ORGANISMS PROTECTING CHILDREN AGAINST GASTROINTESTINAL INFECTIONS
RU2013126604A (en) NON-REPLICATING PROBIOTIC BACTERIA AND PREVENTION OR THERAPY OF INFECTIONS IN ORDER TO REDUCE THE MISSION OF VISITS OF SCHOOL OR INSTITUTIONS OF DAY CARE FOR CHILDREN
CA3150903C (en) Probiotic for inhibiting growth of proteus mirabilis, and fermentation broth and application thereof
WO2021221594A3 (en) Multi-probiotic oil combination containing borage oil and production method thereof
Fijan et al. Probiotic microorganisms and their benefit to human health
Lim et al. Current market trends and perspectives of probiotics
Michaylova et al. Probiotic candidates among dairy Lactobacilli and Streptococcus thermophiles strains for control of the oral pathogen Porphyromonas gingivalis
Laterza et al. Benefits of multistrain bacteria formulations for health
TR202006605A2 (en) MULTI PROBIOTIC OIL COMBINATION WITH SAMEFA OIL AND PRODUCTION METHOD
Үсенова et al. Study of the biochemical properties of bacteria of the genus Lactobacillus and their identification
Petrova et al. Lactic acid bacteria against pathogenic microbes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21795739

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21795739

Country of ref document: EP

Kind code of ref document: A2